Hammer Johann, Howell Stuart, Bytzer Peter, Horowitz Michael, Talley Nicholas J
Abteilung für Gastroenterologie und Hepatologie, Universitätsklinik für Innere Medizin IV, Vienna, Austria.
Am J Gastroenterol. 2003 Feb;98(2):391-8. doi: 10.1111/j.1572-0241.2003.07236.x.
GI symptoms form distinct symptom clusters in community samples when factor and cluster analysis is applied. However, this has not been studied in diabetic populations, despite clear evidence that GI complaints are common in patients with diabetes mellitus (DM). This study aimed to describe clustering of GI symptoms among individuals with and without diabetes mellitus, and to describe associations of symptom clustering in diabetes mellitus, with self-reported glucose control and treatment.
A large population survey (n = 15,000) was used to identify a cohort with diabetes mellitus. Items assessing therapy and quality of glycemic control were included, as were those assessing 16 common GI symptoms. Latent GI symptom factors were extracted by factor analysis and used in a k-means cluster analysis. The latter serves to group individuals according to commonalities in symptom profiles. The association of cluster group membership to glycemic control and diabetic treatment was described by logistic regression.
Factor analysis identified four latent symptom factors, which accounted for 69.3% of the total variance. These were labeled Upper GI/Dysmotility, Diarrhea, Constipation, and Vomiting/Nausea. The k-means analysis produced a five-cluster solution, which included a "health" group and four "diseased" groups, each identified by a predominant symptom: Upper GI/Dysmotility symptoms, Nausea/Vomiting, Diarrhea, and Constipation. After adjustment for age and gender, poor glycemic control predicted membership in all disease clusters, when compared separately with the health group. Oral hypoglycemic drugs predicted membership in the Nausea/Vomiting cluster (OR = 5.13) when used alone, and membership in the Nausea/Vomiting (OR = 10.12) and Upper GI/Dysmotility cluster (OR = 10.12) when used in combination with insulin.
Diabetes can be grouped according to common GI symptoms. Glycemic control and treatment for DM predict membership of symptom clusters.
在社区样本中,应用因子分析和聚类分析时,胃肠道(GI)症状会形成不同的症状群。然而,尽管有明确证据表明胃肠道不适在糖尿病患者中很常见,但尚未在糖尿病群体中进行过此类研究。本研究旨在描述糖尿病患者和非糖尿病患者中胃肠道症状的聚类情况,并描述糖尿病中症状聚类与自我报告的血糖控制及治疗之间的关联。
一项大型人群调查(n = 15,000)被用于确定一个糖尿病队列。纳入了评估治疗和血糖控制质量的项目,以及评估16种常见胃肠道症状的项目。通过因子分析提取潜在的胃肠道症状因子,并将其用于k均值聚类分析。后者用于根据症状特征的共性对个体进行分组。通过逻辑回归描述聚类组成员与血糖控制和糖尿病治疗之间的关联。
因子分析确定了四个潜在症状因子,它们占总方差的69.3%。这些因子被标记为上消化道/动力障碍、腹泻、便秘和呕吐/恶心。k均值分析产生了一个五聚类解决方案,其中包括一个“健康”组和四个“疾病”组,每个组由一种主要症状确定:上消化道/动力障碍症状、恶心/呕吐、腹泻和便秘。在对年龄和性别进行调整后,与健康组分别比较时,血糖控制不佳预示着所有疾病聚类的成员身份。口服降糖药单独使用时预示着恶心/呕吐聚类的成员身份(比值比[OR]=5.13),与胰岛素联合使用时预示着恶心/呕吐聚类(OR = 10.12)和上消化道/动力障碍聚类(OR = 10.12)的成员身份。
糖尿病可根据常见的胃肠道症状进行分组。糖尿病的血糖控制和治疗预示着症状聚类的成员身份。